EOSINOPHILIC ESOPHAGITIS (EOE)
Clinical trials for EOSINOPHILIC ESOPHAGITIS (EOE) explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC ESOPHAGITIS (EOE) trials appear
Sign up with your email to follow new studies for EOSINOPHILIC ESOPHAGITIS (EOE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Head-to-Head: which EoE drug fights scarring better?
Disease control ENROLLING_BY_INVITATIONThis study compares two treatments for eosinophilic esophagitis (EoE): swallowed budesonide (Eohilia) and injected dupilumab (Dupixent). Researchers want to see which one better improves esophageal diameter and reduces scarring after 12 weeks. The trial enrolls 60 adults with act…
Matched conditions: EOSINOPHILIC ESOPHAGITIS (EOE)
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug shows promise for swallowing disorder
Disease control OngoingThis study tests an experimental drug called NSI-8226 (solrikitug) in adults with eosinophilic esophagitis, a condition that causes trouble swallowing due to inflamed esophagus. About 184 participants will receive either the drug or a placebo to see if it reduces inflammation and…
Matched conditions: EOSINOPHILIC ESOPHAGITIS (EOE)
Phase: PHASE2 • Sponsor: Uniquity One (UNI) • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC